SOD2 and cancer: Antioxidants or overexpression of ROS-scavenging enzymes, such as Cu- or Mn-superoxide dismutase and catalase, blocked the plasma-induced death of cancer cells and abrogated the mitochondrial aberrations, suggesting that oxidative targeting of mitochondria by plasma precedes selective death of cancer cells.